Literature DB >> 19135616

Aldosterone and cardiovascular disease.

Krishna K Gaddam, Eduardo Pimenta, Saima Husain, David A Calhoun.   

Abstract

Aldosterone is an adrenal hormone that regulates sodium, fluid, and potassium balance. Jerome Conn first described the syndrome of autonomous and excessive aldosterone secretion or "primary aldosteronism." Contrary to the historical belief, recent studies indicate that primary aldosteronism is a common cause of hypertension with a prevalence of 5-10% among general hypertensive patients. Various animal models have demonstrated that aldosterone in association with a high salt diet results in target-organ inflammation and fibrosis. Similarly, cross-sectional and observational human studies have demonstrated the association of aldosterone with development and severity of hypertension, congestive heart failure, coronary artery disease, chronic kidney disease, and metabolic syndrome. Several interventional studies have also demonstrated the beneficial effects of mineralocorticoid receptor antagonists in these disease processes, particularly hypertension, heart failure, and post myocardial infarction, further supporting the role of aldosterone in their pathogenesis. We review the role of aldosterone in these various cardiovascular disease processes along with potential mechanisms and treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19135616     DOI: 10.1016/j.cpcardiol.2008.10.002

Source DB:  PubMed          Journal:  Curr Probl Cardiol        ISSN: 0146-2806            Impact factor:   5.200


  16 in total

Review 1.  The roles of cyclic nucleotide phosphodiesterases (PDEs) in steroidogenesis.

Authors:  Li-Chun Lisa Tsai; Joseph A Beavo
Journal:  Curr Opin Pharmacol       Date:  2011-09-29       Impact factor: 5.547

2.  Simultaneous surgery for chronic aortic dissection and adrenal adenoma with primary aldosteronism.

Authors:  Hidekazu Hirai; Toshihiko Shibata; Yasuyuki Sasaki; Hiromichi Fujii; Shoji Kubo; Shigefumi Suehiro
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-05-07

3.  Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats.

Authors:  Erika I Boesen; Douglas L Williams; Jennifer S Pollock; David M Pollock
Journal:  Clin Exp Pharmacol Physiol       Date:  2010-10       Impact factor: 2.557

Review 4.  Mineralocorticoid receptor antagonists and the metabolic syndrome.

Authors:  Amir Tirosh; Rajesh Garg; Gail K Adler
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

Review 5.  Have the renin-angiotensin-aldosterone system perturbations in cardiovascular disease been exhausted?

Authors:  Sulaf J Mansur; Fadi G Hage; Suzanne Oparil
Journal:  Curr Cardiol Rep       Date:  2010-11       Impact factor: 2.931

6.  Curable congestive heart failure in patients with primary aldosteronism: two cases reports.

Authors:  Zijun Chen; Zhe Zhang; Qianlan Xi; Guimei Huang; Liya Wang
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 4.060

7.  PKCδ Mediates Mineralocorticoid Receptor Activation by Angiotensin II to Modulate Smooth Muscle Cell Function.

Authors:  Qing Lu; Ana P Davel; Adam P McGraw; Sitara P Rao; Brenna G Newfell; Iris Z Jaffe
Journal:  Endocrinology       Date:  2019-09-01       Impact factor: 4.736

8.  Predictors of resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenoma.

Authors:  Ra Mi Kim; Jandee Lee; Euy-Young Soh
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

9.  Predictors of successful outcome after adrenalectomy for primary aldosteronism.

Authors:  Wei Wang; WeiLie Hu; XiaoMing Zhang; BangQi Wang; Chen Bin; Hai Huang
Journal:  Int Surg       Date:  2012 Apr-Jun

10.  Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism.

Authors:  Adam P McGraw; Jessamyn Bagley; Wei-Sheng Chen; Carol Galayda; Heather Nickerson; Andrea Armani; Massimiliano Caprio; Peter Carmeliet; Iris Z Jaffe
Journal:  J Am Heart Assoc       Date:  2013-02-22       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.